{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:47:01Z","timestamp":1771001221057,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.thromres.2015.01.027","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T17:54:24Z","timestamp":1422640464000},"page":"684-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Comparison of automated von Willebrand factor activity assays"],"prefix":"10.1016","volume":"135","author":[{"given":"Annette","family":"Timm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hillarp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malou","family":"Philips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens P.","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2015.01.027_bb0005","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0010","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/beha.2001.0139","article-title":"Congenital von Willebrand disease type 3: clinical manifestations, pathophysiology and molecular biology","volume":"14","author":"Eikenboom","year":"2001","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"10.1016\/j.thromres.2015.01.027_bb0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-2143(97)90019-6","article-title":"von Willebrand disease and quantitative variation in von Willebrand factor","volume":"130","author":"Mohlke","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0006-3495(02)75161-8","article-title":"Selectin-like kinetics and biomechanics promote rapid platelet adhesion in flow: the GPIb(alpha)-vWF tether bond","volume":"83","author":"Doggett","year":"2002","journal-title":"Biophys J"},{"issue":"6","key":"10.1016\/j.thromres.2015.01.027_bb0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI7569","article-title":"A revised model of platelet aggregation","volume":"105","author":"Kulkarni","year":"2000","journal-title":"J Clin Invest"},{"issue":"18","key":"10.1016\/j.thromres.2015.01.027_bb0030","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"Foster","year":"1987","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.thromres.2015.01.027_bb0035","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajh.1090","article-title":"Population differences in von Willebrand factor levels affect the diagnosis of von Willebrand disease in African-American women","volume":"67","author":"Miller","year":"2001","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.thromres.2015.01.027_bb0045","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1046\/j.1538-7836.2003.00367.x","article-title":"Measurement of von Willebrand factor activity: relative effects of ABO blood type and race","volume":"1","author":"Miller","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0050","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1055\/s-0038-1651343","article-title":"Letter: A method for assaying von Willebrand factor (ristocetin cofactor)","volume":"34","author":"Macfarlane","year":"1975","journal-title":"Thromb Diath Haemorrh"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0038-1653684","article-title":"Ristocetin\u2013a new tool in the investigation of platelet aggregation","volume":"26","author":"Howard","year":"1971","journal-title":"Thromb Diath Haemorrh"},{"issue":"5","key":"10.1016\/j.thromres.2015.01.027_bb0060","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1055\/s-2006-947863","article-title":"Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation","volume":"32","author":"Kitchen","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"5","key":"10.1016\/j.thromres.2015.01.027_bb0065","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1055\/s-2006-947862","article-title":"An external quality assessment program for von Willebrand factor laboratory analysis: an overview from the European concerted action on thrombosis and disabilities foundation","volume":"32","author":"Meijer","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0070","first-page":"56","article-title":"Evaluation of two automated methods for measurement of the ristocetin cofactor activity of von Willebrand factor","volume":"88","author":"Miller","year":"2002","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2516.2010.02419.x","article-title":"Evaluation of an automated platelet-based assay of ristocetin cofactor activity","volume":"17","author":"Lawrie","year":"2011","journal-title":"Haemophilia"},{"issue":"10","key":"10.1016\/j.thromres.2015.01.027_bb0080","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/j.1538-7836.2010.04029.x","article-title":"Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol","volume":"8","author":"Hillarp","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"6","key":"10.1016\/j.thromres.2015.01.027_bb0085","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman Program for the Molecular and Clinical Biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0037-1613765","article-title":"A reliable and reproducible ELISA method to measure ristocetin cofactor activity of von Willebrand factor","volume":"83","author":"Vanhoorelbeke","year":"2000","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1160\/TH04-04-0402","article-title":"Plasma glycocalicin as a source of GPIbalpha in the von Willebrand factor ristocetin cofactor ELISA","volume":"93","author":"Vanhoorelbeke","year":"2005","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.thromres.2015.01.027_bb0100","article-title":"Measurement in Medicine: The analysis of Method Comparison Studies","volume":"32","author":"Altman","year":"1983","journal-title":"Statistician"},{"issue":"5","key":"10.1016\/j.thromres.2015.01.027_bb0105","first-page":"28","article-title":"Statistics for Laboratory Method Comparison Studies","author":"Magari","year":"2002","journal-title":"BioPharm"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0110","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/hae.12064","article-title":"A comparative evaluation of a new automated assay for von Willebrand factor activity","volume":"19","author":"Lawrie","year":"2013","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.thromres.2015.01.027_bb0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/hae.12264","article-title":"A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen","volume":"20","author":"Stufano","year":"2014","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.thromres.2015.01.027_bb0120","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.thromres.2014.09.024","article-title":"Towards improved diagnosis of von Willebrand disease: Comparative evaluations of several automated von Willebrand factor antigen and activity assays","volume":"134","author":"Favaloro","year":"2014","journal-title":"Thromb Res"},{"issue":"3","key":"10.1016\/j.thromres.2015.01.027_bb0125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/ijlh.12218","article-title":"Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin","volume":"36","author":"Graf","year":"2014","journal-title":"Int J Lab Hematol"},{"issue":"2","key":"10.1016\/j.thromres.2015.01.027_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.thromres.2014.04.033","article-title":"Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo","volume":"134","author":"Geisen","year":"2014","journal-title":"Thromb Res"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384815000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T01:47:51Z","timestamp":1651110471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384815000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0049384815000456"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2015.01.027","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of automated von Willebrand factor activity assays","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2015.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}